摘要
Cancer immunotherapy is causing a paradigm shift in tile way cancer researchers think about treating people with the disease. Unlike traditional therapies, immunotherapy harnesses the immune system to fight cancer instead of targeting the ttlmor itself＂ Lung adenocarcinoma is frequently diagnosed in advanced stages with poor prognosis and has become the most common tumor treated by immunotherapy.
Cancer immunotherapy is causing a paradigm shift in tile way cancer researchers think about treating people with the disease. Unlike traditional therapies, immunotherapy harnesses the immune system to fight cancer instead of targeting the ttlmor itself＂ Lung adenocarcinoma is frequently diagnosed in advanced stages with poor prognosis and has become the most common tumor treated by immunotherapy.
